Wiener Privatklinik
Wiener Privatklinik
Austria, Vienna
Christoph Zielinski
44 years of experience
accreditations :
Clinic is certified :
Non-Hodgkin's lymphoma treatment cost in Austria typically runs from $2,500 to $5,500 for chemotherapy, while advanced interventions like bone marrow transplantation can range between $50,000 and $270,000. Total expenses depend on the disease stage, treatment protocols, and clinic type. Patients often find competitive pricing in Austria compared to the US. Most specialized hematology-oncology care is centered in Vienna.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Austria
Bookimed Expert Insight: For complex lymphoma cases, seeking professors affiliated with the Medical University of Vienna ensures high-level expertise. Univ.-Prof. Dr. Wolfgang Köstler at Wiener Privatklinik focuses on personalized cancer medicine and targeted therapies. Patients requiring long-term management benefit from Confraternitaet Private Hospital, where Prof. Johannes Drach directs specialized malignant lymphoma programs. These private institutions offer JCI-accredited environments and multilingual support for international patients seeking premium care.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Chemotherapy | from $2,430 | from $2,500 | from $2,500 |
| Bone marrow transplantation | from $36,000 | from $140,000 | from $71,782 |
| Autologous bone marrow transplantation | from $31,500 | from $50,000 | from $40,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Non-Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Non-Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Non-Hodgkin's lymphoma treatment journey.
Univ. Prof. Dr. Wolfgang Köstler is a leading expert in personalized cancer medicine, specializing in breast cancer and gynecologic malignancies.
Professor Drach leads the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital – one of Europe's largest. He combines clinical expertise with academic leadership.
The doctor is a leading figure in medical oncology, hematology, and cancer immunotherapy, with a career spanning over four decades. After earning a medical degree from the University of Vienna in the 1970s, the doctor completed specialist training in internal medicine and oncology in the 1980s.
In the 1990s, the doctor was appointed Head of the Clinical Division of Oncology at the Medical University of Vienna, leading Austria's largest oncology department. The 2000s saw the founding of the Comprehensive Cancer Center Vienna, integrating patient care, research, and education.
The doctor served as President of the Central European Cooperative Oncology Group in the 2010s and currently holds positions as Chairman of the Vienna Cancer Center and Medical Director of Wiener Privatklinik’s International Oncology Center.
Austria hosts top hematology centers offering advanced therapies for Non-Hodgkin lymphoma. Vienna General Hospital (AKH Wien) provides CAR T-cell therapy and complex bone marrow transplants. Wiener Privatklinik and Confraternität & Goldenes Kreuz are premier private options. These facilities combine specialized hematopathology with personalized immunotherapy and targeted biological treatments.
Bookimed Expert Insight: Patient data highlights that Wiener Privatklinik offers a compact, efficient environment. Its International Oncology Center includes 400 physicians and 30 specialized departments. This ensures rapid coordination between hematopathology and oncologists. Such speed is crucial for starting time-sensitive lymphoma treatments like immunotherapy. Unlike large public hospitals, private clinics often provide faster diagnostic turnaround for complex subtyping.
Patient Consensus: Patients value how centers coordinate biopsy, staging, and treatment starts without long delays. Those choosing private care in Vienna appreciate the direct communication during online consultations with oncologists.
Austria provides advanced modalities for Non-Hodgkin lymphoma including CAR T-cell therapy and targeted immunotherapy. Specialized centers offer allogeneic and autologous bone marrow transplantation for complex cases. Precision radiation and monoclonal antibody therapies are standard. These treatments are delivered by board-certified hematologists at JCI or ISO-accredited facilities.
Bookimed Expert Insight: Many leading specialists at Wiener Privatklinik also hold professorships at the Medical University of Vienna. This dual role creates a bridge between private personalized care and the latest clinical research. Dr. Wolfgang Köstler and Professor Johannes Drach represent this high level of academic expertise. They often participate in early clinical trials for individualized systemic therapies.
Patient Consensus: Patients emphasize the value of online consultations for reviewing complex histology results before traveling. Many recommend requesting a second pathology review to ensure the lymphoma subtype is accurately identified for targeted treatment.
Austrian hemato-oncologists determine non-Hodgkin lymphoma protocols by matching patient metrics with Onkopedia guidelines. These standards are developed by the Austrian, German, and Swiss hematology societies. Specialists use precise histological subtyping and PET-CT staging to choose between observation, immunotherapy, or intensive chemotherapy.
Bookimed Expert Insight: Protocol accuracy in Austria often relies on the deep academic ties of its physicians. Many specialists at Wiener Privatklinik also serve as professors at the Medical University of Vienna. This ensures patients receive protocols based on the latest biomarker developments and translational cancer research.
Patient Consensus: Patients note that treatment does not always start immediately. Many are surprised to learn that observation is often the safest path for certain slow-growing lymphoma subtypes.
Patients undergoing Non-Hodgkin lymphoma treatment in Austria can expect short-term fatigue, nausea, and mouth sores. Long-term effects may include peripheral neuropathy or persistent mental fog. Leading centers like Wiener Privatklinik offer specialized oncology care to manage these reactions and support overall recovery.
Bookimed Expert Insight: Lymphoma specialists in Vienna, such as Professor Dr. Johannes Drach, often emphasize pre-treatment nutrition and lifestyle assessments. Data from Wiener Privatklinik shows that involving over 400 specialists, many from the Medical University of Vienna, allows for highly personalized systemic therapies. This collaborative approach helps identify patients at higher risk for specific toxicities before the first infusion begins.
Patient Consensus: Patients note that extreme fatigue often peaks several days after treatment rather than immediately. Many emphasize that proactive oral care is essential to prevent painful mouth sores before they start.
International patients can enroll in Non-Hodgkin lymphoma clinical trials in Austria. Acceptance is determined by specific protocol rules and ethical committee approvals. Medical eligibility requires meeting precise genetic and staging criteria. Patients must often provide translated pathology reports and recent molecular testing results for review.
Bookimed Expert Insight: Clinical trial access in Vienna is often tied to academic affiliations. Specialists like Dr. Wolfgang Köstler and Dr. Johannes Drach are both professors at the Medical University of Vienna. This connection is vital because university-linked private clinics like Wiener Privatklinik often facilitate advanced systemic therapies. Choosing a doctor with deep ties to the Medical University can streamline the clinical review of your medical records.